US clears 3-D mapping system for right atrium use:
This article was originally published in Clinica
The US FDA has cleared Endocardial Solution's EnSite 3000 mapping system for diagnosing complex arrhythmias in the right atrium of the heart. By providing three-dimensional mapping of the whole chamber, the system makes possible ablation therapy for patients with atrial arrhythmias, said the St Paul, Minnesota-based company. The FDA is currently reviewing a premarket approval application to use the system for left ventricular investigations. The system is already available in Europe for both right atrial and left ventricular use - under a distribution agreement with Medtronic.
You may also be interested in...
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.